Related Experiment Video
Updated: Jul 14, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency
Nima Parvaneh1, Shohreh Shahmahmoudi, Hamideh Tabatabai
1Department of Pediatrics, Infectious Disease Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Vaccine-associated paralytic poliomyelitis (VAPP) is a rare complication of oral polio vaccine. We describe a fatal case of VAPP in an 8-month-old boy with Major Histocompatibility Class II deficiency. The isolated poliovirus was a Sabin type 2-type 1 recombinant that showed 1.4% VP1 divergence from Sabin type 2.
Insights
Vaccine-associated paralytic poliomyelitis (VAPP) is a rare oral polio vaccine complication. A fatal VAPP case in an infant with immune deficiency involved a rare poliovirus recombinant.
Area of Science:
- Immunology
- Virology
- Pediatrics
Background:
- Vaccine-associated paralytic poliomyelitis (VAPP) is a rare but serious complication associated with the oral polio vaccine (OPV).
- Major Histocompatibility Complex (MHC) Class II deficiency is a primary immunodeficiency disorder affecting cellular immunity.
Observation:
- This report details a fatal case of VAPP in an 8-month-old boy diagnosed with MHC Class II deficiency.
- The patient developed paralytic poliomyelitis following OPV administration.
Findings:
- The poliovirus isolated from the patient was a Sabin type 2-type 1 recombinant.
- Genetic analysis revealed a 1.4% divergence in the VP1 gene compared to the Sabin type 2 strain, suggesting potential alterations in viral properties.
Implications:
- This case highlights the risks of OPV in immunocompromised individuals, particularly those with primary immunodeficiencies.
- Understanding the characteristics of poliovirus recombinants is crucial for assessing VAPP risk and informing vaccination strategies.
More Related Videos
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Related Concept Videos
Poliomyelitis
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease
Vaccinations
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Diphtheria